Dozens of state attorneys general have urged Congress to ban or clarify intoxicating hemp-derived THC products, citing safety concerns and enforcement challenges. This coordinated push signals tightening regulations ahead — and rising compliance risks for hemp operators nationwide.

Cannabis stocks like Tilray, Canopy Growth, and Greenlane are seeing renewed investor attention thanks to increased trading volume and optimism around policy reform. Here’s what’s driving the resurgence — and what it means for the future of cannabis business and investment.

Massachusetts-based MariMed is expanding into New York through a licensing partnership with Farm 2 Hand LLC, giving it access to the state’s $6 billion adult-use cannabis market. The deal highlights the growing trend of compliance-focused brand licensing as a key strategy for national cannabis growth.

West Virginia’s medical cannabis program has generated nearly $34 million in taxes and fees since 2021 — yet none of it has been spent. As the state’s funds sit idle, patients and operators are left wondering when the benefits of legalization will finally reach communities in need.

Two-thirds of licensed cannabis businesses in Los Angeles owe nearly $400 million in unpaid taxes, forcing the city to consider a tax amnesty program. The shortfall exposes deeper challenges facing California’s cannabis industry — from over-taxation to compliance fatigue.